In Vivo Flow Cytometry May Be Next Step in Identifying CTCs
A team of scientists have developed a noninvasive optical method, in vivo flow cytometry (IVFC) to monitor CTCs in xenograft tumor models.
Read MorePosted by Chris Wolski | Aug 26, 2021 | Flow Cytometry |
A team of scientists have developed a noninvasive optical method, in vivo flow cytometry (IVFC) to monitor CTCs in xenograft tumor models.
Read MorePosted by Chris Wolski | Aug 13, 2021 | Prostate |
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging...
Read MorePosted by Chris Wolski | Aug 12, 2021 | Cancer |
Alverno Laboratories and Ibex Medical Analytics have announced a deal to deploy Ibex’s AI-powered Galen platform.
Read MorePosted by Melanie Hamilton-Basich | Jul 15, 2021 | Digital Imaging |
Gestalt Diagnostics and Deep Bio announced a strategic relationship to develop an integrated workflow for pathologists to use AI algorithms directly within Gestalt’s PathFlow platform to diagnose prostate cancer.
Read MorePosted by Chris Wolski | Jul 9, 2021 | Cancer |
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read More